Trial Profile
Efficacy and tolerability of moxifloxacin and clindamycin in patients with peridontal abscesses or inflammatory infiltrates.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2011
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Clindamycin
- Indications Bacterial infections; Periodontal abscess
- Focus Therapeutic Use
- Acronyms MOCLI
- 10 May 2011 Microbiological (secondary endpoint) results presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy.
- 05 Nov 2010 New trial record.